Drug analysis by direct liquid introduction micro liquid chromatography mass spectrometry

Abstract

The analytical capabilities of a micro high performance liquid chromatograph interfaced to an unchanged quadrupole mass spectrometer are presented. Continuous monitoring of the total micro liquid chromatographic effluent allows full scan chemical ionization mass spectra of from one to five nanograms of drugs and their metabolites to be recorded. The interface is a simple, inexpensive device which can be assembled from commercially available components. An eight microliter per minute flow rate of the micro liquid chromatographic eluant allows separation and identification of biologically important substances not amenable to gas chromatography mass spectrometry techniques. The sensitivity of micro liquid chromatography mass spectrometry performed as described is comparable with gas chromatography mass spectrometry and is achieved by introducing the total micro liquid chromatographic effluent into the chemical ionization ion source of the mass spectrometer. Selected ion monitoring provides 20 pg detection limits of phenothiazine tranquilizers injected on column.

Induction of Apoptosis in Human Breast Cancer Cells via Caspase Pathway by Vernodalin Isolated from Centratherum anthelminticum (L.) Seeds

“…The advancement of technology such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) have speed up the process of drug screening and discovery [13]. LC-MS is a highly sensitivity and selectivity method used in drug development at many different stages including profiling of secondary metabolites in plants, impurities detection, metabolic stability or degradant analysis [14], [15].…”

Nano‐liquid chromatography—direct electron ionization mass spectrometry: improving performance by a new ion source adapter

“…Inside the ion source, the eluent is vaporized and ionized by an electron beam, and the ions are accelerated into the quadrupole mass analyzer. Several groups investigated the direct coupling between LC and EI‐MS starting in 1970 . Since then, several variations of the interface have been developed, until the development of atmospheric pressure ionization methods revolutionized the LC‐MS interfacing and LC/EI‐MS disappeared from the community's research focus.…”

The Role of Pharmacokinetic Studies in Drug Discovery: Where are We Now, How Did We Get Here and Where are We Going?

“…There were four keys steps that made PK optimization an achievable medicinal chemistry goal, thrusting drug metabolism and pharmacokinetics to the heart of discovery projects. The key steps in approximate chronological order were: bioanalytical: development of the thermospray interface enabling the coupling of HPLC and triple quadrupole mass spectrometers [5]; mathematical: the development of clearance concepts in pharmacokinetics, allowing AUC to be derived from dose, and rate of elimination from drug concentrations [6]; experimental: development of in vitro metabolizing systems, enabling prediction of clearance from animal and human liver preparations [7]; conceptual: the realization that drug metabolism and pharmacokinetics (DMPK) properties were driven by physicochemical and chemical properties and were therefore predictable and readily amenable to optimization [8]. With these developments not only was the need for DMPK in drug design readily recognizable, but the practical steps to deliver a cost-effective and efficient process were in place.…”